RUBY
Rubius Therapeutics, Inc
RUBY
RUBY
Delisted
RUBY was delisted on the 6th of March, 2023.
67 hedge funds and large institutions have $1.36B invested in Rubius Therapeutics, Inc in 2019 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 35 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
67
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$20.2M | |
| 2 | +$15M | |
| 3 | +$10.4M | |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
+$9.37M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$9.08M |
Top Sellers
| 1 | -$457K | |
| 2 | -$71.1K | |
| 3 | -$32.2K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$22K |
| 5 |
Invesco
Atlanta,
Georgia
|
-$5.86K |